Тёмный

Managing CLL in Relapsed Patients Refractory to BTK & BCL2 Inhibitors | Lydia Scarfò, MD | ASH 2022 

HealthTree Foundation for Blood Cancers
Подписаться 202
Просмотров 18
50% 1

Interview with Lydia Scarfò, MD of Università Vita-Salute San Raffaele Milan at ASH 2022. Filmed December 12, 2022.
The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/
Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate cure for blood cancers. Join today at www.healthtree.org/

Опубликовано:

 

5 май 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Relapsed/Refractory CLL Treatment Options
59:54
Diagnosed with High-Risk Myeloma: What Now?
1:25:40
Просмотров 2,1 тыс.
Preparing Your Home Post Stem Cell Transplant
25:27
Просмотров 2,6 тыс.
Natasha's lung cancer story
5:25
Просмотров 725
Acute Myeloid Leukemia | Clinical Presentation
10:15
Просмотров 663 тыс.
Hemochromatosis - My Iron Overload Story (2019)
14:45
Просмотров 103 тыс.
How Are CLL Medicines' Side Effects Managed?
1:05:14
Retinitis Pigmentosa (RP)- MYRHIAS PERSPEKTIVE
15:02
Просмотров 3,7 тыс.
How Does Inflammation Relate to Cancer?
59:39
Просмотров 6 тыс.